ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS – Get Rating) was the target of a large drop in short interest in the month of January. As of January 15th, there was short interest totalling 14,900 shares, a drop of 77.5% from the December 31st total of 66,300 shares. Based on an average daily trading volume, of 19,100 shares, the days-to-cover ratio is presently 0.8 days.
Institutional Investors Weigh In On ProShares UltraShort Nasdaq Biotechnology
Several institutional investors have recently added to or reduced their stakes in the business. Citadel Advisors LLC lifted its stake in ProShares UltraShort Nasdaq Biotechnology by 234.0% during the second quarter. Citadel Advisors LLC now owns 34,972 shares of the company's stock worth $943,000 after purchasing an additional 24,501 shares during the last quarter. IMC Chicago LLC lifted its stake in ProShares UltraShort Nasdaq Biotechnology by 11.1% during the third quarter. IMC Chicago LLC now owns 23,335 shares of the company's stock worth $590,000 after purchasing an additional 2,332 shares during the last quarter. Finally, UBS Group AG increased its position in ProShares UltraShort Nasdaq Biotechnology by 54.7% during the first quarter. UBS Group AG now owns 1,371 shares of the company's stock worth $33,000 after buying an additional 485 shares during the period.
Get
ProShares UltraShort Nasdaq Biotechnology alerts:
ProShares UltraShort Nasdaq Biotechnology Stock Performance
Shares of BIS traded up $0.20 during midday trading on Thursday, hitting $18.36. The company had a trading volume of 8,844 shares, compared to its average volume of 25,385. The company's 50-day simple moving average is $19.13 and its 200-day simple moving average is $21.74. ProShares UltraShort Nasdaq Biotechnology has a 1 year low of $17.88 and a 1 year high of $35.64.
ProShares UltraShort Nasdaq Biotechnology Company Profile
(Get Rating)
ProShares Ultra Nasdaq Biotechnology (the Fund) seeks investment results for a single day only, not for longer periods. The Fund seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day's returns compounded over the period, which will very likely differ from twice (200%) the return of the Nasdaq Biotechnology Index (the Index) for that period.
Read More
- Get a free copy of the StockNews.com research report on ProShares UltraShort Nasdaq Biotechnology (BIS)
- Chevron Delights Shareholders with $75 Billion in Share Buybacks
- The Future Of E-Commerce: Analysis And New Data
- Levi Strauss Is A Good Fit For Income Investors
- 3 Small Caps That Have Big Upside
- Mullen Automotive: The Good News, The Bad And The Ugly Outlook
Receive News & Ratings for ProShares UltraShort Nasdaq Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProShares UltraShort Nasdaq Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
ProShares UltraShort 纳斯达克生物技术公司(纳斯达克股票代码:BIS — 获取评级)是1月份空头利率大幅下降的目标。截至1月15日,空头利息总额为14,900股,较12月31日的66,300股下降了77.5%。根据19,100股的平均每日交易量,目前的天数回报率为0.8天。
机构投资者关注ProShares UltraShort 纳斯达克生物技术公司
一些机构投资者最近增加了或减少了在该业务中的股份。Citadel Advisors LLC在第二季度将其在ProShares UltraShort Nasdaq Biotechology的股份提高了234.0%。Citadel Advisors LLC在上个季度又购买了24,501股股票后,现在拥有该公司34,972股股票,价值94.3万美元。IMC Chicago LLC在第三季度将其在ProShares UltraShort Nasdaq Biotechology的股份提高了11.1%。IMC Chicago LLC在上个季度又购买了2332股股票后,现在拥有该公司23,335股股票,价值59万美元。最后,瑞银集团股份公司在第一季度将其在ProShares UltraShort Nasdaq Biotechology的头寸增加了54.7%。瑞银集团股份公司在此期间又购买了485股股票后,现在拥有该公司1371股股票,价值33,000美元。
得到
ProShares 超空纳斯达克生物技术 警报:
ProShares 超空纳斯达克生物技术股票表现
国际清算银行股价在周四午盘交易中上涨0.20美元,触及18.36美元。该公司的交易量为8,844股,而平均交易量为25,385股。该公司的50天简单移动平均线为19.13美元,其200天简单移动平均线为21.74美元。ProShares UltraShort Nasdaq Biotechlogy的1年低点为17.88美元,1年高点为35.64美元。
ProShares UltraShort 纳斯达克生物技术公司简介
(获取评级)
ProShares Ultra Nasdaq 生物技术公司(以下简称 “基金”)仅寻求单日的投资业绩,而不是长期的投资业绩。该基金寻求扣除费用和支出前的每日投资业绩,这些业绩相当于该指数每日表现的两倍(200%)。基金在超过一个交易日的时间内的回报将是该期间每天的复合回报的结果,这很可能与该时期纳斯达克生物技术指数(“指数”)回报率的两倍(200%)有所不同。
阅读更多
- 免费获取 StockNews.com 关于 ProShares UltraShort 纳斯达克生物技术(BIS)的研究报告
- 雪佛龙以750亿美元的股票回购令股东感到高兴
- 电子商务的未来:分析和新数据
- 李维·施特劳斯非常适合收入投资者
- 3 个有很大上升空间的小盘股
- Mullen Automotive:好消息、坏消息和丑陋前景
接收ProShares UltraShort《纳斯达克生物技术日报》的新闻和评级——在下方输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收ProShares UltraShort Nasdaq Biotechorty及相关公司的最新新闻和分析师评级的简明每日摘要。